Tenaya Therapeutics Inc (TNYA)

May 23, 2026

What do we know so far from TN-201 trial? - Moomoo

May 23, 2026

May 23, 2026

TN-201 and TN-401 - Moomoo

May 23, 2026

May 22, 2026

TNYA Technical Analysis | Trend, Signals & Chart Patterns | TENAYA THERAPEUTICS INC (NASDAQ:TNYA) - ChartMill

May 22, 2026

May 21, 2026

Tenaya Therapeutics' gene therapy data highlights early heart rhythm improvements - MSN

May 21, 2026

May 20, 2026

Tenaya Therapeutics CMO Tingley Whittemore sells $2,476 in stock By Investing.com - Investing.com Australia

May 20, 2026

May 19, 2026

Tenaya Therapeutics CEO Ali Faraz sells $2,689 in shares - Investing.com UK

May 19, 2026

May 19, 2026

Tenaya Therapeutics CMO Tingley Whittemore sells $2,476 in stock - Investing.com UK

May 19, 2026

May 19, 2026

Tenaya Therapeutics CEO Ali Faraz sells $2,689 in shares By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

Tenaya Therapeutics SVP Tomohiro Higa reports $1,177 stock sale - Investing.com UK

May 19, 2026

May 19, 2026

Tenaya Therapeutics SVP Tomohiro Higa reports $1,177 stock sale By Investing.com - Investing.com Canada

May 19, 2026

May 19, 2026

Tenaya (TNYA) CEO sells 3,390 shares tied to RSU tax withholding - Stock Titan

May 19, 2026

May 19, 2026

Tenaya Therapeutics (TNYA) CMO sells 3,121 shares for tax withholding - Stock Titan

May 19, 2026

May 19, 2026

Tenaya Therapeutics (TNYA) SVP sells 1,485 shares to cover RSU taxes - Stock Titan

May 19, 2026

May 19, 2026

Canaccord Genuity Sticks to Their Buy Rating for Tenaya Therapeutics (TNYA) - The Globe and Mail

May 19, 2026

May 19, 2026

Tenaya Therapeutics, Inc. (TNYA) reports Q1 loss, misses revenue estimates - MSN

May 19, 2026

May 18, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 18, 2026

May 18, 2026

H.C. Wainwright Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $3 - Moomoo

May 18, 2026

May 18, 2026

CCORF Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $5 - Moomoo

May 18, 2026

May 17, 2026

Tenaya Therapeutics, Inc. (TNYA) Discusses RIDGE-1 Phase Ib/II Data on TN-401 Gene Therapy for PKP2-Associated ARVCSlideshow (NASDAQ:TNYA) 2026-05-17 - Seeking Alpha

May 17, 2026

May 16, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

May 16, 2026

May 16, 2026

Tenaya Therapeutics' Gene Therapy Data Highlights Early Heart Rhythm Improvements - Sahm

May 16, 2026

May 15, 2026

LifeSci Capital Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Raises Target Price to $4 - Moomoo

May 15, 2026

May 15, 2026

Tenaya Therapeutics, Inc. (TNYA) Presents at Heart Failure 2026Slideshow (NASDAQ:TNYA) 2026-05-15 - Seeking Alpha

May 15, 2026

May 15, 2026

Chardan Capital Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $8 - Moomoo

May 15, 2026

May 15, 2026

Tenaya Shares Rise on Positive Data From ARVC Study - Moomoo

May 15, 2026

May 15, 2026

Transcript : Tenaya Therapeutics, Inc.Special Call - marketscreener.com

May 15, 2026

May 15, 2026

Positive interim data from cohorts 1 and 2 of Tenaya's Ridge-1 phase 1b/2 clinical trial of TN-401 - marketscreener.com

May 15, 2026

May 15, 2026

Tenaya Therapeutics presents new RIDGE-1 trial results showing arrhythmia reduction in PKP2-associated ARVC - Traders Union

May 15, 2026

May 15, 2026

Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC - The Manila Times

May 15, 2026

May 15, 2026

Tenaya Therapeutics Reports Significant Reductions in Premature Ventricular Contractions in Interim Results from TN-401 Gene Therapy Clinical Trial - Quiver Quantitative

May 15, 2026

May 15, 2026

Tenaya reports interim gene therapy trial results for heart condition - Investing.com

May 15, 2026

May 15, 2026

Early TN-401 gene therapy trial eases dangerous heart rhythms - Stock Titan

May 15, 2026

May 14, 2026

Tenaya Therapeutics (TNYA) price target increased by 11.11% to 10.20 - MSN

May 14, 2026

May 14, 2026

TNYA.O Technical Analysis & Stock Price Forecast - Intellectia AI

May 14, 2026

May 13, 2026

Tenaya Therapeutics partners on parent attitudes survey for gene therapy in pediatric cardiomyopathy - Traders Union

May 13, 2026

May 13, 2026

Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation - Moomoo

May 13, 2026

May 12, 2026

Eugene Braunwald legacy in HCM research honored by Tenaya Therapeutics - Traders Union

May 12, 2026

May 11, 2026

Tenaya Therapeutics (TNYA) Is Up 26.6% After TN-401 Data Buzz and Narrower Losses Has The Bull Case Changed? - Yahoo Finance

May 11, 2026

May 11, 2026

TradingKey - TradingKey

May 11, 2026

May 11, 2026

Why Tenaya Therapeutics (TNYA) Is Up 26.6% After New TN-401 Data Near-Term Catalysts - simplywall.st

May 11, 2026

May 09, 2026

LifeSci Capital Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $3 - Moomoo

May 09, 2026